Healthcare >> Analyst Interviews >> April 16, 2007

MICRO-CAP BIOTECHNOLOGY COMPANIES – RAHUL JASUJA – MDB CAPITAL GROUP LLC

TWST: How would you describe the general attitude toward biotech at this point?

Dr. Jasuja: Of late, investors have shown an inclination to stay away from

riskier stories - that has affected